1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Country/Region, 2017, 2022 & 2028
2.2 Short Bowel Syndrome(SBS) Drugs Segment by Type
2.2.1 Glucagon-Like Peptide-2(GLP-2)
2.2.2 Growth Hormone
2.2.3 Glutamine
2.2.4 Other
2.3 Short Bowel Syndrome(SBS) Drugs Sales by Type
2.3.1 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Type (2017-2022)
2.4 Short Bowel Syndrome(SBS) Drugs Segment by Sale Channel
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Retail Pharmacies
2.5 Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
2.5.1 Global Short Bowel Syndrome(SBS) Drugs Sale Market Share by Sale Channel (2017-2022)
2.5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Sale Channel (2017-2022)
2.5.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Sale Channel (2017-2022)
3 Global Short Bowel Syndrome(SBS) Drugs by Company
3.1 Global Short Bowel Syndrome(SBS) Drugs Breakdown Data by Company
3.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Company (2020-2022)
3.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Short Bowel Syndrome(SBS) Drugs Revenue by Company (2020-2022)
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Company
3.4 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Product Location Distribution
3.4.2 Players Short Bowel Syndrome(SBS) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Short Bowel Syndrome(SBS) Drugs by Geographic Region
4.1 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Geographic Region
4.2 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Country/Region
4.3 Americas Short Bowel Syndrome(SBS) Drugs Sales Growth
4.4 APAC Short Bowel Syndrome(SBS) Drugs Sales Growth
4.5 Europe Short Bowel Syndrome(SBS) Drugs Sales Growth
4.6 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Growth
5 Americas
5.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country
5.1.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
5.1.2 Americas Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
5.2 Americas Short Bowel Syndrome(SBS) Drugs Sales by Type
5.3 Americas Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region
6.1.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022)
6.1.2 APAC Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022)
6.2 APAC Short Bowel Syndrome(SBS) Drugs Sales by Type
6.3 APAC Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Short Bowel Syndrome(SBS) Drugs by Country
7.1.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
7.1.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
7.2 Europe Short Bowel Syndrome(SBS) Drugs Sales by Type
7.3 Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs by Country
8.1.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type
8.3 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs
10.3 Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
10.4 Industry Chain Structure of Short Bowel Syndrome(SBS) Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short Bowel Syndrome(SBS) Drugs Distributors
11.3 Short Bowel Syndrome(SBS) Drugs Customer
12 World Forecast Review for Short Bowel Syndrome(SBS) Drugs by Geographic Region
12.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Forecast by Region
12.1.1 Global Short Bowel Syndrome(SBS) Drugs Forecast by Region (2023-2028)
12.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Short Bowel Syndrome(SBS) Drugs Forecast by Type
12.7 Global Short Bowel Syndrome(SBS) Drugs Forecast by Sale Channel
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Short Bowel Syndrome(SBS) Drugs Product Offered
13.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Short Bowel Syndrome(SBS) Drugs Product Offered
13.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Emmaus Medical
13.3.1 Emmaus Medical Company Information
13.3.2 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Offered
13.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Emmaus Medical Main Business Overview
13.3.5 Emmaus Medical Latest Developments
13.4 Ardelyx
13.4.1 Ardelyx Company Information
13.4.2 Ardelyx Short Bowel Syndrome(SBS) Drugs Product Offered
13.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ardelyx Main Business Overview
13.4.5 Ardelyx Latest Developments
13.5 Naia Pharmaceuticals
13.5.1 Naia Pharmaceuticals Company Information
13.5.2 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Naia Pharmaceuticals Main Business Overview
13.5.5 Naia Pharmaceuticals Latest Developments
13.6 Nutrinia
13.6.1 Nutrinia Company Information
13.6.2 Nutrinia Short Bowel Syndrome(SBS) Drugs Product Offered
13.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nutrinia Main Business Overview
13.6.5 Nutrinia Latest Developments
13.7 OxThera
13.7.1 OxThera Company Information
13.7.2 OxThera Short Bowel Syndrome(SBS) Drugs Product Offered
13.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 OxThera Main Business Overview
13.7.5 OxThera Latest Developments
13.8 Sancilio Pharmaceuticals
13.8.1 Sancilio Pharmaceuticals Company Information
13.8.2 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sancilio Pharmaceuticals Main Business Overview
13.8.5 Sancilio Pharmaceuticals Latest Developments
13.9 Zealand Pharma
13.9.1 Zealand Pharma Company Information
13.9.2 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Offered
13.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Zealand Pharma Main Business Overview
13.9.5 Zealand Pharma Latest Developments
14 Research Findings and Conclusion
【掲載企業】
Merck、 Takeda、 Emmaus Medical、 Ardelyx、 Naia Pharmaceuticals、 Nutrinia、 OxThera、 Sancilio Pharmaceuticals、 Zealand Pharma